Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
How GLP-1 Receptor Agonists May Protect Against Cancer: The Mechanisms The cancer-preventive potential of GLP-1 therapy is understood to arise from several converging biological mechanisms, each addressing a distinct pathway through which metabolic dysfunction promotes oncogenesis
SLN124, a GalNAc-siRNA conjugate targeting TMPRSS6, efficiently prevents iron overload in hereditary haemochromatosis type 1
Glutathione metabolism and parkinsons disease
Wiley Sigalos JT, Pastuszak AW
US$ 23.76
US$ 23.04
US$ 27.38
US$ 21.08
US$ 22.06
US$ 20.86
